tiprankstipranks
Advertisement
Advertisement

CAMRF Stock Latest News

Camurus Targets Real‑World Evidence in New Acromegaly Study With Octreotide Depot
Company AnnouncementsCamurus Targets Real‑World Evidence in New Acromegaly Study With Octreotide Depot
13s ago
CAMRF
Camurus announces expansion of collaboration with Eli Lilly
PremiumThe Fly
Camurus announces expansion of collaboration with Eli Lilly
3d ago
LLY
Camurus Wins Lilly Option Exercise, Extending Long-Acting Cardiometabolic Drug Deal
PremiumCompany Announcements
Camurus Wins Lilly Option Exercise, Extending Long-Acting Cardiometabolic Drug Deal
3d ago
Camurus Repurchases Series C Shares to Fund Long-Term Incentive Plan
PremiumCompany Announcements
Camurus Repurchases Series C Shares to Fund Long-Term Incentive Plan
7d ago
Camurus AGM Backs Board, Withholds Dividend and Approves New Performance Share Plan
PremiumCompany Announcements
Camurus AGM Backs Board, Withholds Dividend and Approves New Performance Share Plan
7d ago
Camurus Holds Course on 2026 Outlook Despite Softer Q1 Sales
PremiumCompany AnnouncementsCamurus Holds Course on 2026 Outlook Despite Softer Q1 Sales
23d ago
Camurus Targets Severe Diseases With Long-Acting Drug Innovations
Premium
Company Announcements
Camurus Targets Severe Diseases With Long-Acting Drug Innovations
1M ago
Camurus calls 2026 AGM with capital measures and new incentive plan on agenda
Premium
Company Announcements
Camurus calls 2026 AGM with capital measures and new incentive plan on agenda
1M ago
Camurus Expands Share Capital After Employee Stock Option Exercises
PremiumCompany Announcements
Camurus Expands Share Capital After Employee Stock Option Exercises
2M ago
Camurus Expands Share Capital After Employee Stock Option Exercises
PremiumCompany Announcements
Camurus Expands Share Capital After Employee Stock Option Exercises
3M ago
Camurus Strengthens Executive Team With New Corporate Development Chief
PremiumCompany Announcements
Camurus Strengthens Executive Team With New Corporate Development Chief
4M ago
Camurus AB Earnings Call: Growth, FX and U.S. Push
PremiumCompany Announcements
Camurus AB Earnings Call: Growth, FX and U.S. Push
4M ago
Camurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio
PremiumCompany AnnouncementsCamurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio
4M ago
CAMRF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CAMRF Upcoming Earnings Report: What to Expect?
4M ago
Camurus announces FDA acceptance of NDA resubmission for Oclaiz
Premium
The Fly
Camurus announces FDA acceptance of NDA resubmission for Oclaiz
5M ago
Camurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing
PremiumCompany Announcements
Camurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing
5M ago
Camurus Increases Share Capital After Employee Stock Option Exercise
PremiumCompany Announcements
Camurus Increases Share Capital After Employee Stock Option Exercise
5M ago
Camurus Increases Shares and Votes Following Employee Stock Option Exercise
PremiumCompany Announcements
Camurus Increases Shares and Votes Following Employee Stock Option Exercise
6M ago
Camurus Announces Nomination Committee for AGM 2026
PremiumCompany Announcements
Camurus Announces Nomination Committee for AGM 2026
7M ago
Camurus AB Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsCamurus AB Earnings Call: Growth Amid Challenges
7M ago
Camurus Reports Positive Phase 1b Results for Monthly Semaglutide Depot
Premium
Company Announcements
Camurus Reports Positive Phase 1b Results for Monthly Semaglutide Depot
7M ago
Camurus AB Reports Strong Q3 Growth Amid Revised Outlook
Premium
Company Announcements
Camurus AB Reports Strong Q3 Growth Amid Revised Outlook
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >